Abbott’s (ABT) Diabetes Arm Booms, Neuromodulation Sales Soft Posted byZacks Equity Research February 2, 2022 Leave a comment on Abbott’s (ABT) Diabetes Arm Booms, Neuromodulation Sales Soft Even though COVID-19 case rates are surging in the United States and other geographies, Abbott is seeing growth in its consumer-facing businesses like nutrition, EPD and diabetes care.